Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome

被引：8
|
作者：
Tanaka, Atsushi [1 ]
Nakamura, Tsukasa [2 ]
Sato, Eiichi [2 ]
Ueda, Yoshihiko [3 ]
Node, Koichi [1 ]
机构：
[1] Saga Univ, Dept Cardiovasc Med, Saga, Japan
[2] Shinmatsudo Cent Gen Hosp, Dept Internal Med, Div Nephrol, Matsudo, Chiba, Japan
[3] Dokkyo Univ, Koshigaya Hosp, Dept Pathol, Soka, Saitama, Japan
来源：
INTERNAL MEDICINE | 2017年 / 56卷 / 02期
关键词：
aquaporin-2 (AQP-2); idiopathic membranous nephropathy (IMN); nephrotic syndrome; prednisolone (PSL); tolvaptan; CHRONIC-KIDNEY-DISEASE; DECOMPENSATED HEART-FAILURE; ARGININE-VASOPRESSIN;
D O I：
10.2169/internalmedicine.56.7539
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This case report discusses the clinical indication for immunosuppressants in patients with idiopathic membranous nephropathy (IMN). Because this disease occasionally shows spontaneous remission, it is necessary to determine the predictive values for a therapeutic effect in order to provide appropriate treatment. Two distinct cases described herein illustrate the different effects of tolvaptan in responders and non-responders, according to the pre-treatment levels of AQP-2 immunostaining in the samples from renal biopsy and urinary levels of AQP-2 and osmolality, suggesting that these values may be useful predictors of response to tolvaptan in patients with nephrotic IMN.
引用
收藏
页码：191 / 196
页数：6
相关论文
共 50 条
  • [21] Herbal Medicine "Shulifenxiao" Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
    Cui, Hailan
    Fu, Frank Qiang
    Liu, Baoli
    Liu, Wei Jing
    Liu, Yu Ning
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] PREVALENCE OF GENETIC RISK FACTORS RELATED WITH THROMBOPHILIA AND HYPOFIBRINOLYSIS IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY AND NEPHROTIC SYNDROME
    Ismail, Gener
    Andronesi, Andreea
    Jurubita, Roxana
    Bobeica, Raluca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 194 - 194
  • [23] ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome
    Ruggenenti, P
    Mosconi, L
    Vendramin, G
    Moriggi, M
    Remuzzi, A
    Sangalli, F
    Remuzzi, G
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (03) : 381 - 391
  • [24] Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy
    Wenling Ye
    Yingyi Wang
    Yubing Wen
    Hang Li
    Xuemei Li
    International Urology and Nephrology, 2014, 46 : 1247 - 1251
  • [25] Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy
    McQuarrie, Emily P.
    Stirling, Catherine M.
    Geddes, Colin C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) : 235 - 242
  • [26] The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy
    Goumenos, DS
    Kalliakmani, P
    Tsakas, S
    Sotsiou, F
    Vlachojannis, JG
    CLINICAL NEPHROLOGY, 2004, 61 (01) : 17 - 24
  • [27] Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy
    Ye, Wenling
    Wang, Yingyi
    Wen, Yubing
    Li, Hang
    Li, Xuemei
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (06) : 1247 - 1251
  • [28] Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
    Lili Liu
    Haitao Wang
    Ban Zhao
    Xin Liu
    Ying Sun
    Yonghui Mao
    International Urology and Nephrology, 2022, 54 : 331 - 341
  • [29] Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
    Liu, Lili
    Wang, Haitao
    Zhao, Ban
    Liu, Xin
    Sun, Ying
    Mao, Yonghui
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (02) : 331 - 341
  • [30] EFFECT OF DIETARY PROTEINS AND LIPIDS IN PATIENTS WITH MEMBRANOUS NEPHROPATHY AND NEPHROTIC SYNDROME
    DAMICO, G
    REMUZZI, G
    MASCHIO, G
    GENTILE, MG
    GOTTI, E
    OLDRIZZI, L
    MANNA, G
    MECCA, G
    RUGIU, C
    FELLIN, G
    CLINICAL NEPHROLOGY, 1991, 35 (06) : 237 - 242
12345